First Horizon Advisors, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 16 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
First Horizon Advisors, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$5,986
+25.8%
387
+27.7%
0.00%
Q2 2023$4,760
-77.2%
303
-76.1%
0.00%
-100.0%
Q1 2023$20,895
+118.5%
1,268
+106.9%
0.00%
Q4 2022$9,562
+139.0%
613
+68.9%
0.00%
Q3 2022$4,000
-20.0%
3630.0%0.00%
Q2 2022$5,000363
+967.6%
0.00%
Q1 2022$0
-100.0%
34
-92.8%
0.00%
Q4 2021$6,000
-14.3%
4750.0%0.00%
Q3 2021$7,000
-61.1%
475
-56.1%
0.00%
-100.0%
Q2 2021$18,000
+100.0%
1,082
+116.0%
0.00%0.0%
Q1 2021$9,000
+12.5%
501
+11.1%
0.00%0.0%
Q4 2020$8,000
+14.3%
4510.0%0.00%0.0%
Q3 2020$7,000
+75.0%
451
+112.7%
0.00%
Q1 2019$4,000
+300.0%
212
+226.2%
0.00%
Q3 2018$1,0000.0%650.0%0.00%
Q2 2018$1,0000.0%650.0%0.00%
Q1 2018$1,0000.0%650.0%0.00%
Q4 2017$1,0000.0%65
-7.1%
0.00%
Q3 2017$1,0000.0%700.0%0.00%
Q2 2017$1,0000.0%70
-6.7%
0.00%
Q1 2017$1,00075
+316.7%
0.00%
Q4 2016$0180.0%0.00%
Q3 2016$018
+50.0%
0.00%
Q2 2016$0120.0%0.00%
Q1 2016$012
+300.0%
0.00%
Q4 2015$030.0%0.00%
Q3 2015$030.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2018
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders